GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023
GlycoMimetics, Inc. (Nasdaq: GLYC) a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its financial...
GlycoMimetics to Report First Quarter 2023 Financial Results on May 3, 2023
GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2023 financial results on Wednesday, May 3, 2023, at 8:30 a.m. ET.
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2022
GlycoMimetics, Inc. (Nasdaq: GLYC) a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its financial...